Department of Radiation Oncology, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
Curr Treat Options Oncol. 2022 Oct;23(10):1388-1404. doi: 10.1007/s11864-022-01012-9. Epub 2022 Sep 10.
Several seminal papers over the last decade have furthered our recognition of radiation-induced heart disease (RIHD) as an important potential toxicity following radiation therapy (RT) to the chest. Investigators continue to evaluate the subacute and long-term effects of RT. In addition, studies are determining whether certain cardiac substructures are more sensitive to radiation, working to identify risk factors for the development of RIHD, and testing screening and mitigation strategies for RIHD. Multiple groups and expert consensus guidelines have published whole-heart and cardiac substructure dose constraints based on available data and cancer type. The authors recommend readers to familiarize themselves with the guidelines for screening and mitigating RIHD in adults and children, which advocate for cardiovascular risk assessment and reduction before and following RT, as well as cardiovascular imaging at appropriate follow-up intervals for early recognition of subclinical cardiovascular disease. Referrals to cardiology or cardio-oncology can also be helpful in prevention, screening, and mitigation strategies.
过去十年中的几项重要研究进一步认识到,放射性心脏病(RIHD)是胸部放射治疗(RT)后一种重要的潜在毒性。研究人员继续评估 RT 的亚急性和长期影响。此外,研究正在确定某些心脏亚结构对辐射是否更敏感,努力确定 RIHD 发展的危险因素,并测试 RIHD 的筛查和缓解策略。多个小组和专家共识指南已根据现有数据和癌症类型发布了全心脏和心脏亚结构剂量限制。作者建议读者熟悉成人和儿童 RIHD 的筛查和缓解指南,该指南主张在 RT 前后进行心血管风险评估和降低,以及在适当的随访间隔进行心血管成像,以早期发现亚临床心血管疾病。向心脏病学或心脏肿瘤学转诊也有助于预防、筛查和缓解策略。